Premium
Continuous positive airway pressure for obstructive sleep apnoea does not improve asthma control
Author(s) -
Ng Susanna S.S.,
Chan TatOn,
To KinWang,
Chan Ken K.P.,
Ngai Jenny,
Yip WingHo,
Lo Rachel L.P.,
Ko Fanny W.S.,
Hui David S.C.
Publication year - 2018
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.13363
Subject(s) - medicine , continuous positive airway pressure , asthma , epworth sleepiness scale , positive airway pressure , obstructive sleep apnea , airway , anesthesia , quality of life (healthcare) , physical therapy , polysomnography , apnea , nursing
Background and objective Unrecognized obstructive sleep apnoea syndrome (OSAS) may lead to poor asthma control despite optimal therapy. We assessed asthma control, airway responsiveness, daytime sleepiness and health status at baseline and 3 months after continuous positive airway pressure (CPAP) treatment among asthma patients with nocturnal symptoms and OSAS. Methods Patients with nocturnal asthma symptoms despite receiving at least moderate‐dose inhaled corticosteroid and long‐acting bronchodilators underwent a home sleep study using ‘Embletta’ portable diagnostic system. Patients with significant OSAS (apnoea–hypopnoea index (AHI) ≥10/h) were randomized to receive either CPAP or conservative treatment for 3 months. Results Among 145 patients recruited, 122 underwent sleep study with 41 (33.6%) having AHI ≥10/h. Patients with significant OSAS had higher BMI (27.4 (5.1) vs 25.1 (4.5) kg/m 2 , P = 0.016), bigger neck circumference (36.6 (3.1) vs 34.8 (3.6) cm, P = 0.006) and lower minimum SaO 2 (80.7 (6.6) vs 87.2 (3.9) %, P < 0.001). Using intention‐to‐treat analysis among 37 patients with AHI ≥10/h (CPAP group ( n = 17) vs control group ( n = 20)), there was no significant difference in Asthma Control Test score (CPAP 3.2 (2.7) vs control 2.4 (5.7), P = 0.568) but the CPAP group had a greater improvement in Epworth Sleepiness Scale (−3.0 (4.5) vs 0.5(3.8), P = 0.014), Asthma Quality of Life Questionnaire (0.6 (0.8) vs 0.02 (0.7), P = 0.022) and vitality domain in the SF‐36 questionnaire (14.7 (16.8) vs 0.3 (16.2), P = 0.012) after 3 months. Data are presented as mean (SD) unless otherwise stated. Conclusion A high prevalence of OSAS was found among patients with asthma and snoring. CPAP therapy for 3 months did not enhance asthma control but improved daytime sleepiness, quality of life and vitality.